Tea consumption and attenuation of biological aging: a longitudinal analysis from two cohort studiesResearch in context
Summary: Background: The biological aging process can be modified through lifestyle interventions to prevent age-related diseases and extend healthspan. However, evidence from population-based studies on whether tea consumption could delay the biological aging process in humans remains limited. Methods: This study included 7931 participants aged 30–79 years from the China Multi-Ethnic Cohort (CMEC) Study and 5998 participants aged 37–73 years from the UK Biobank (UKB) who participated in both the baseline and first follow-up surveys. Tea consumption information was collected through questionnaires. Biological age (BA) acceleration was calculated using clinical biomarkers and anthropometric measurements based on the Klemera Doubal method (KDM). Change-to-change analyses were performed to estimate the associations between changes in tea consumption status and changes in BA acceleration using multiple linear models. Follow-up adjusted for baseline analyses were further conducted to examine the prospective exposure-response relationship between tea consumption and BA acceleration among individuals with constant tea consumption status. Findings: During a median follow-up of 1.98 (1.78, 2.16) years in the CMEC and 4.50 (3.92, 5.00) years in the UKB, tea consumption was consistently associated with attenuated BA acceleration in both cohorts. Transitioning from nondrinking to tea-drinking was associated with decreased BA acceleration (CMEC: β = −0.319, 95% CI: −0.620 to −0.017 years; UKB: β = −0.267, 95% CI: −0.831 to 0.297 years) compared to consistent nondrinking. Even stronger associations were found in consistent tea drinkers. The exposure-response relationship suggested that consuming around 3 cups of tea or 6–8 g of tea leaves per day may offer the most evident anti-aging benefits. Interpretation: Tea consumption was associated with attenuated BA acceleration measured by KDM, especially for consistent tea drinkers with moderate consumption. Our findings highlight the potential role of tea in developing nutrition-oriented anti-aging interventions and guiding healthy aging policies. Funding: National Natural Science Foundation of China (Grant No. 82273740)..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
---|---|
Enthalten in: |
The Lancet Regional Health. Western Pacific - 42(2024), Seite 100955- |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yi Xiang [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Biological aging |
---|
doi: |
10.1016/j.lanwpc.2023.100955 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ091543460 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ091543460 | ||
003 | DE-627 | ||
005 | 20240412095325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240412s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.lanwpc.2023.100955 |2 doi | |
035 | |a (DE-627)DOAJ091543460 | ||
035 | |a (DE-599)DOAJ54e9d5d99e2d4bc9a80aa4c4e5f19094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RA1-1270 | |
100 | 0 | |a Yi Xiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tea consumption and attenuation of biological aging: a longitudinal analysis from two cohort studiesResearch in context |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Summary: Background: The biological aging process can be modified through lifestyle interventions to prevent age-related diseases and extend healthspan. However, evidence from population-based studies on whether tea consumption could delay the biological aging process in humans remains limited. Methods: This study included 7931 participants aged 30–79 years from the China Multi-Ethnic Cohort (CMEC) Study and 5998 participants aged 37–73 years from the UK Biobank (UKB) who participated in both the baseline and first follow-up surveys. Tea consumption information was collected through questionnaires. Biological age (BA) acceleration was calculated using clinical biomarkers and anthropometric measurements based on the Klemera Doubal method (KDM). Change-to-change analyses were performed to estimate the associations between changes in tea consumption status and changes in BA acceleration using multiple linear models. Follow-up adjusted for baseline analyses were further conducted to examine the prospective exposure-response relationship between tea consumption and BA acceleration among individuals with constant tea consumption status. Findings: During a median follow-up of 1.98 (1.78, 2.16) years in the CMEC and 4.50 (3.92, 5.00) years in the UKB, tea consumption was consistently associated with attenuated BA acceleration in both cohorts. Transitioning from nondrinking to tea-drinking was associated with decreased BA acceleration (CMEC: β = −0.319, 95% CI: −0.620 to −0.017 years; UKB: β = −0.267, 95% CI: −0.831 to 0.297 years) compared to consistent nondrinking. Even stronger associations were found in consistent tea drinkers. The exposure-response relationship suggested that consuming around 3 cups of tea or 6–8 g of tea leaves per day may offer the most evident anti-aging benefits. Interpretation: Tea consumption was associated with attenuated BA acceleration measured by KDM, especially for consistent tea drinkers with moderate consumption. Our findings highlight the potential role of tea in developing nutrition-oriented anti-aging interventions and guiding healthy aging policies. Funding: National Natural Science Foundation of China (Grant No. 82273740). | ||
650 | 4 | |a Biological aging | |
650 | 4 | |a Tea consumption | |
650 | 4 | |a Change-to-change analysis | |
650 | 4 | |a Follow-up adjusted for baseline analysis | |
650 | 4 | |a Exposure-response relationship | |
653 | 0 | |a Public aspects of medicine | |
700 | 0 | |a Hao Xu |e verfasserin |4 aut | |
700 | 0 | |a Hongxiang Chen |e verfasserin |4 aut | |
700 | 0 | |a Dan Tang |e verfasserin |4 aut | |
700 | 0 | |a Zitong Huang |e verfasserin |4 aut | |
700 | 0 | |a Yuan Zhang |e verfasserin |4 aut | |
700 | 0 | |a Zhenghong Wang |e verfasserin |4 aut | |
700 | 0 | |a Ziyun Wang |e verfasserin |4 aut | |
700 | 0 | |a Yangla |e verfasserin |4 aut | |
700 | 0 | |a Mingming Han |e verfasserin |4 aut | |
700 | 0 | |a Jianzhong Yin |e verfasserin |4 aut | |
700 | 0 | |a Xiong Xiao |e verfasserin |4 aut | |
700 | 0 | |a Xing Zhao |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t The Lancet Regional Health. Western Pacific |d Elsevier, 2021 |g 42(2024), Seite 100955- |w (DE-627)DOAJ078609631 |x 26666065 |7 nnns |
773 | 1 | 8 | |g volume:42 |g year:2024 |g pages:100955- |
856 | 4 | 0 | |u https://doi.org/10.1016/j.lanwpc.2023.100955 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/54e9d5d99e2d4bc9a80aa4c4e5f19094 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2666606523002730 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2666-6065 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 42 |j 2024 |h 100955- |